Effects of Baduanjin on anxiety, depressive symptoms, and quality of life in patients with primary glaucoma…

Randomized trialComplementary therapies in clinical practice· Jul 2026

Effects of Baduanjin on anxiety, depressive symptoms, and quality of life in patients with primary glaucoma: A randomized controlled trial.

Zhen Zeng, Xuejia Li, Xiaolin Ma … Ling Qin

GlaucomaRandomized trialTreatmentQ1IF 4.0

Baduanjin exercise improves overall quality of life in patients with primary glaucoma.

Effects of Baduanjin on anxiety, depressive symptoms, and quality of life in patients with primary glaucoma: A randomized controlled trial.

Zhen Zeng … Ling Qin

Complementary therapies in clinical practice · Jul 2026

Background

Primary glaucoma is the leading cause of irreversible vision loss worldwide.

Methods

A total of 112 patients with primary glaucoma were enrolled and randomly assigned in a 1:1 ratio to either the Baduanjin exercise group (n = 56) or the routine care control group (n = 56).

n = 112 patients

adjusted difference -4.97

Results

adjusted difference -4.97

Baduanjin exercise led to a better overall quality of life than routine care

n = 112 patients

More results

Significant group × baseline interactions were observed for the Hospital Anxiety and Depression Scale for anxiety (Hospital Anxiety and Depression Scale for anxiety) (F = 66.481, P < 0.001),the Hospital Anxiety and Depression Scale for depression (Hospital Anxiety and Depression Scale for depression) (F = 37.116, P < 0.001), and Pittsburgh Sleep Quality Index (F = 10.591, P = 0.002), indicating that the intervention effects varied by baseline severity.

More results

Conditional analyses showed that the benefits were more pronounced in patients with higher baseline symptom levels.

“

Conclusion · 1 of 3

Baduanjin exercise effectively alleviates anxiety and depressive symptoms, reduces perceived sleep problems, and improves domain-specific quality of life (glare/dark adaptation and outdoor mobility) in patients with primary glaucoma.

Conclusion · 2 of 3

These benefits are more pronounced in those with higher baseline symptom burden.

Conclusion · 3 of 3

Baduanjin represents a safe, feasible, and scalable non-pharmacological adjunctive intervention that can complement conventional glaucoma care, enhancing mental health and daily functional adaptation.

Effects of Baduanjin on anxiety, depressive symptoms, and quality of life in patients with primary glaucoma: A randomized controlled trial.

Effects of Baduanjin on anxiety, depressive symptoms, and quality of life in patients with primary glaucoma: A randomized controlled trial.

Related papers